Rare disease companies call for UK leadership in supporting access to new treatments
London, United Kingdom, 06/11/2023 - A group of companies developing innovative new medicines for rare diseases, working together through their trade association, is calling for the UK to lead greater collaboration between stakeholders, and uptake of best practice both in the UK and internationally, to improve access to new treatments for patients.The call from the BioIndustry Association (BIA)’s Rare Disease Industry Group (RDIG) is informed by a new report by the BIA, with research provided by global consultancy firm PwC, which has highlighted the progress that has been made in improving